Wonbiogen Co., Ltd.

Research Wonbiogen Co., Ltd. (307280.KQ) on Bullrun: market cap KRW 40.09B, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is KRW 40.09B; dividend yield is 2.4%.

Peer valuation comparison

Latest dividend yield is 2.38% versus a Healthcare sector median of 2.4%.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18KRW 40.09Bn/a2.4%140

Dividend history

Latest trailing dividend snapshot: annual dividend/share 140 KRW, yield 2.4%.

About Wonbiogen Co., Ltd.

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co., Ltd. was founded in 2006 and is headquartered in Gumi-si, South Korea.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Wonbiogen Co., Ltd.'s market cap?

Wonbiogen Co., Ltd.'s market capitalization is KRW 40.09B.

Does Wonbiogen Co., Ltd. pay a dividend?

Wonbiogen Co., Ltd. has a dividend yield of 2.4%.

What does Wonbiogen Co., Ltd. do?

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co., Ltd. was founded in 2006 and is headquartered in Gumi-si, South Korea.